학술논문

Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate – The ICE randomized clinical trial
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, November 2023, 194)
Subject
Language
English
ISSN
18790852
09598049